Minimum Effective Volume of 0.375% Bupivacaine in Interscalene Brachial Plexus Block
NCT01667315
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Shoulder Surgery
Interventions
DRUG:
Bupivacaine 0,375%
Sponsor
Federal University of São Paulo